Efficacy of cilostazol for intracranial arterial stenosis evaluated by digital subtraction angiography/magnetic resonance angiography

Advances in Therapy

Volumn 28, Issue 10, 2011, Pages 866-878

  Yamada, Keiichi ^a   Fujimoto, Yasuhiro ^a  

^a KANSAI ELECTRIC POWER CO   (Japan)

Author keywords

cilostazol; digital subtraction angiography; intracranial arterial stenosis; magnetic resonance angiography

Indexed keywords

CILOSTAZOL;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BASILAR ARTERY OBSTRUCTION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEMIPARESIS; HUMAN; HYPESTHESIA; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; OCCLUSIVE CEREBROVASCULAR DISEASE; SPEECH DISORDER; SUBARACHNOID HEMORRHAGE; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; ARTERIAL OCCLUSIVE DISEASES; CEREBRAL ARTERIES; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PHOSPHODIESTERASE 3 INHIBITORS; TETRAZOLES;

EID: 82355181104     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-011-0060-y     Document Type: Article

References (34)

1. P.G. Borozan J.J. Schuler M.P. LaRosa M.S. Ware D.P. Flanigan 1984 The natural history of isolated carotid siphon stenosis J Vasc Surg 1 744 749 6492305 1:STN:280:DyaL2M%2FjsVSmsA%3D%3D (Pubitemid 15056069)
2. D.R. Craig K. Meguro C. Watridge J.T. Robertson H.J. Barnett A.J. Fox 1982 Intracranial internal carotid artery stenosis Stroke 13 825 828 7147298 10.1161/01.STR.13.6.825 1:STN:280:DyaL3s%2FmvVCnsg%3D%3D (Pubitemid 13251496)
3. D.J. Marzewski A.J. Furlan P. St Louis J.R. Little M.T. Modic G. Williams 1982 Intracranial internal carotid artery stenosis: longterm prognosis Stroke 13 821 824 7147297 10.1161/01.STR.13.6.821 1:STN:280:DyaL3s%2FmvVCguw%3D%3D (Pubitemid 13251495)
4. N.A. Moufarrij J.R. Little A.J. Furlan J.R. Leatherman G.W. Williams 1986 Basilar and distal vertebral artery stenosis: long-term follow up Stroke 17 938 942 3764966 10.1161/01.STR.17.5.938 1:STN:280:DyaL2s%2FitVShsQ%3D%3D (Pubitemid 16000733)
5. R.L. Sacco D.E. Kargman Q. Gu M.C. Zamanillo 1995 Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study Stroke 26 14 20 7839388 10.1161/01.STR.26.1.14 1:STN:280:DyaK2M7ktFehtg%3D%3D
6. J.F. Arenillas C.A. Molina J. Montaner S. Abilleira M.A. González-Sánchez J. Alvarez-Sabín 2001 Progression and clinical recurrence of symptomatic middle cerebral artery stenosis. A long-term follow up transcranial doppler ultrasound study Stroke 32 2898 2904 11739993 10.1161/hs1201.099652 1:STN:280:DC%2BD3MnpslChuw%3D%3D (Pubitemid 33134487)
7. J. Bogousslavsky H.J. Barnett A.J. Fox V.C. Hachinski W. Taylor for the EC/IC Bypass Study Group 1986 Atherosclerotic disease of middle cerebral artery Stroke 17 1112 1120 3544347 10.1161/01.STR.17.6.1112 1:STN:280: DyaL2s7itFamug%3D%3D (Pubitemid 17008939)
8. M.I. Chimowitz J. Kokkinos J. Strong for the Warfarin-Aspirin Symptomatic Intracranial Disease Study Group, et al. 1995 The warfarin-aspirin symptomatic intracranial disease study Neurology 45 1488 1493 7644046 1:STN:280: DyaK2MzntFyrtQ%3D%3D
9. R.N. Corston B.E. Kendall J. Marshall 1984 Prognosis in middle cerebral artery stenosis Stroke 15 237 241 6701930 10.1161/01.STR.15.2.237 1:STN:280:DyaL2c7kslyrtQ%3D%3D (Pubitemid 14171252)
10. R.C. Hinton J.P. Mohr R.H. Ackerman L.B. Adair C.M. Fisher 1979 Symptomatic middle cerebral artery stenosis Ann Neurol 5 152 157 426478 10.1002/ana.410050208 1:STN:280:DyaE1M7ktlKisw%3D%3D (Pubitemid 9195814)
11. S.E. Kasner M.I. Chimowitz M.J. Lynn, et al. 2006 Predictors of ischemic stroke in territory of a symptomatic intracranial arterial stenosis Circulation 113 553 563 10.1161/CIRCULATIONAHA.105.578229
12. The WASID study group. 1998 Prognosis of patients with symptomatic vertebral or basilar artery stenosis Stroke 29 1389 1392 10.1161/01.STR.29.7. 1389
13. V.N. Thijs G.W. Albers 2000 Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic thrapy Neurology 55 490 497 10953179 1:STN:280:DC%2BD3cvhsV2ruw%3D%3D (Pubitemid 30647243)
14. R. Kern W. Steinke M. Daffertshofer R. Prager M. Hennerici 2005 Stroke recurrence in patients with symptomatic vs asymptomatic middle cerebral artery disease Neurology 65 859 864 16186524 10.1212/01.wnl.0000175983.76110.59 1:STN:280:DC%2BD2Mrhtl2nsw%3D%3D (Pubitemid 41362130)
15. M.I. Chimowitz M.J. Lynn H. Howlett-Smith Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators, et al. 2005 Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis N Engl J Med 352 1305 1316 15800226 10.1056/NEJMoa043033 1:CAS:528:DC%2BD2MXislCjsLo%3D (Pubitemid 40411497)
16. S.U. Kwon Y.J. Cho J.S. Koo, et al. 2005 Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis Stroke 36 782 786 15746463 10.1161/01.STR.0000157667.06542.b7 1:CAS:528:DC%2BD2MXislait7Y%3D
17. O.B. Samuels G.J. Joseph M.J. Lynn H.A. Smith M.I. Chimowitz 2000 A standard method for measuring intracranial arterial stenosis AJNR 21 643 646 10782772 1:STN:280:DC%2BD3c3kt1yltA%3D%3D (Pubitemid 30210425)
18. R.J. Komotar D.A. Wilson J. Mocco, et al. 2006 Natural history of intracranial atherosclerosis: a critical review Neurosurgery 58 595 601 16575322 10.1227/01.NEU.0000204102.88016.33
19. P. Akins T. Pilgram D.T. Cross 3rd C.J. Moran 1998 Natural history of stenosis from intracranial athrosclerosis by serial angiography Stroke 29 433 438 9472886 10.1161/01.STR.29.2.433 1:STN:280:DyaK1c7jt1ahug%3D%3D (Pubitemid 28086688)
20. K.S. Wong H. Li W.W. Lam Y.L. Chan R. Kay 2002 Progression of middle cerebral artery occlusive disease and relationship with further vascular events after stroke Stroke 33 532 536 11823665 10.1161/hs0202.102602 (Pubitemid 34123401)
21. B.M. Famakin M.I. Chimowitz M.J. Lynn B.J. Stern M.G. George for the WASID Trial Investigators 2009 Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis Stroke 40 1999 2003 19407228 10.1161/STROKEAHA.108.546150
22. M. Mazighi R. Tanasescu X. Ducrocq, et al. 2006 Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study Neurology 66 1187 1191 16636236 10.1212/01.wnl.0000208404.94585.b2 1:STN:280: DC%2BD283ivFSmsw%3D%3D (Pubitemid 43739702)
23. Y. Ikeda M. Kikuchi H. Murakami, et al. 1987 Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on palatelet function ex vivo. Randomized, double blind cross-over study Arzneimittelforschung 37 563 566 2956957 1:STN:280:DyaL2s3pvVKrsQ%3D%3D (Pubitemid 17069147)
24. S. Takahashi K. Oida R. Fujiwara, et al. 1992 Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of smooth muscle cell culture J Cardiovasc Pharmacol 20 900 906 1282592 10.1097/00005344- 199212000-00009 1:CAS:528:DyaK3sXlt1Wmsg%3D%3D (Pubitemid 23001455)
25. H.K. Shin Y.K. Kim K.Y. Kim J.H. Lee K.W. Hong 2004 Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lection-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol Circulation 109 1022 1028 14967724 10.1161/01.CIR.0000117403.64398.53 1:CAS:528:DC%2BD2cXhsFeisbg%3D (Pubitemid 38282856)
26. T. Tanaka T. Ishikawa M. Hagiwara K. Onoda H. Itoh H. Hidaka 1988 Effect of cilostazol, a selective cAMP phosphodiesterase inhibitor, on the contraction of vascular smooth muscle Pharmacology 36 313 320 2841693 10.1159/000138400 1:CAS:528:DyaL1cXhs1Whsro%3D
27. P.J. Van Laar J. van der Grond W.P. Mali J. Hendrikse 2006 Magnetic resonance evaluation of the cerebral circulation in obstructive arterial disease Cerebrovasc Dis 21 297 306 16490938 10.1159/000091534 (Pubitemid 44617292)
28. J. Hendrikse C.J. Klijn A.C. van Huffelen L.J. Kappelle J. van der Grond 2008 Diagnosing cerebral collateral flow patterns: accuracy of non-invasive testing Cerebrovasc Dis 25 430 437 18349537 10.1159/000121344 (Pubitemid 351754639)
29. T. Uehara E. Mori M. Tabuchi Y. Ohsumi A. Yamadori 1994 Detection of occlusive lesions in intracranial arteries by three-dimensional time-of-flight magnetic resonance angiography Cerebrovasc Dis 4 365 370 10.1159/000108509
30. J.E. Heiserman B.P. Drayer P.J. Keller E.K. Fram 1992 Intracranial vascular stenosis and occlusion: evaluation with three-dimensional time-of-flight MR angiography Radiology 185 667 673 1438743 1:STN:280: DyaK3s%2Fms12lsQ%3D%3D
31. T. Hirai Y. Korogi K. Ono, et al. 2002 Prospective evaluation of suspected stenoocclusive disease of intracranial artery: combined MR angiography compared with digital subtraction angiography AJNR 23 93 101 11827880 (Pubitemid 34098265)
32. Y. Korogi M. Takahashi N. Mabuchi, et al. 1994 Intracranial vascular stenosis and occlusion: diagnostic accuracy of three-dimensional, Fourier transform, time-of-flight MR angiography Radiology 193 187 193 8090890 1:STN:280:DyaK2cznslKhtA%3D%3D (Pubitemid 24298022)
33. K.U. Wentz J. Röther A. Schwartz H.P. Mattle R. Suchalla R.R. Edelman 1994 Intracranial vertebrobasilar system: MR angiography Radiology 190 105 110 8259384 1:STN:280:DyaK2c%2Fot1Wmsg%3D%3D
34. J.H. Lee G.T. Oh S.Y. Park, et al. 2005 Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-α formation in low-density lipoprotein receptor-null mice fed high cholesterol J Pharmacol Exp Ther 313 502 509 15734902 10.1124/jpet.104.079780 1:CAS:528:DC%2BD2MXktFemsrs%3D (Pubitemid 40604148)